Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma.

Knopf, Kevin B; Duh, Mei Sheng; Lafeuille, Marie-Hélène; Gravel, Jonathan; Lefebvre, Patrick; Niculescu, Liviu; Ba-Mancini, Abbie; Ma, Esprit; Shi, Hongliang; Comenzo, Raymond L

Knopf, Kevin B; Duh, Mei Sheng; Lafeuille, Marie-Hélène; Gravel, Jonathan; Lefebvre, Patrick; Niculescu, Liviu; Ba-Mancini, Abbie; Ma, Esprit; Shi, Hongliang; Comenzo, Raymond L.

Affiliation

Knopf KB; California Pacific Medical Center, Sutter Health, San Francisco, CA. Electronic address: leroy@alum.MIT.edu.
Duh MS; Analysis Group, Inc, Boston, MA.
Lafeuille MH; Groupe d'analyse, Ltée, Montreal, Quebec, Canada.
Gravel J; Groupe d'analyse, Ltée, Montreal, Quebec, Canada.
Lefebvre P; Groupe d'analyse, Ltée, Montreal, Quebec, Canada.
Niculescu L; Millennium: The Takeda Oncology Company, Cambridge, MA.
Ba-Mancini A; Millennium: The Takeda Oncology Company, Cambridge, MA.
Ma E; Millennium: The Takeda Oncology Company, Cambridge, MA.
Shi H; Millennium: The Takeda Oncology Company, Cambridge, MA.
Comenzo RL; Department of Hematology/Oncology, Tufts Medical Center, Boston, MA.

Clin Lymphoma Myeloma Leuk ; 14(5): 380-8, 2014 Oct.

Article in En | MEDLINE | ID: mdl-25023616

Subject(s)
Key words

Meta-regression analysis; Overall response rate; Random-effect model; Refractory; Relapsed

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Salvage Therapy / Molecular Targeted Therapy / Proteasome Inhibitors / Multiple Myeloma / Neoplasm Proteins / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google